Entries by stingraygroup1

Amethyst Healthcare Announces Júlio Teixeira to Join Amethyst Network

Lisbon / Porto / Braga – 6th October, 2025 Amethyst Healthcare today announces the acquisition of Júlio Teixeira, a well-established provider of radiotherapy services operating in Porto and Braga. This acquisition forms part of Amethyst’s strategic expansion in Western Europe and will strengthen the Group’s capacity to deliver advanced radiotherapy care in Portugal. Júlio Teixeira […]

Stereotactic Body Radiotherapy ‘Effective’ For Lung Cancer

There are many different kinds of radiotherapy, and the effectiveness of selecting one form over another is becoming increasingly apparent as research highlights the relative value of different approaches for particular conditions. This extends to comparisons between using various methods of delivering radiotherapy and alternative treatments. In practice, many cancers are treated using a combination […]

How Can Radiotherapy Help Treat Secondary Cancers?

A cancer diagnosis is a major event in the life of any patient and the response needs to involve both medical and personal support, with an important combination of the two coming through each patient being provided with plenty of information and understanding about their treatment options. Most patients will have limited knowledge of cancer […]

How Radiotherapy Can Help In Treating Blood Cancer

Blood cancer is one of the most common categories of cancer, accounting for up to ten per cent of cancer diagnoses. Among the most familiar forms are leukaemia, lymphoma and myeloma. These can come in different sub-categories: Leukaemia types include acute myeloid leukaemia. This impacts the myeloid cells and causes a loss of white blood cell […]

How Using AI May Increase The Precision Of Radiotherapy

The purpose of a modern radiotherapy centre like ours is somewhat different from those established long ago, when the technology involved and the medical understanding of it were in their infancy. Radiotherapy has been used therapeutically since the turn of the 20th century. But in the early years, it was only able to have a palliative effect on […]

How Private Chemotherapy Can Help Ovarian Cancer Patients

Cancers come in many different forms, but one thing they all have in common is that early diagnosis can make a significant difference to outcomes and treatments. The sooner a cancer is spotted, the less it will have progressed and a particular benefit for the patient can be when a cancer can be treated before […]

Study Favours Radiotherapy Over Surgery For Prostate Cancer

Prostate cancer is a major health issue for men across the world, especially those aged over 50. Although the risk varies significantly with factors such as ethnicity, family history, age and so on, it is the most commonly diagnosed cancer in men, affecting one in eight at some point in their lifetimes. For this reason, finding the right […]

Why Prostate Cancer Patients Need Personalised Treatment

A key feature of our treatment programmes at Amethyst Healthcare is to offer personalised care that is tailored to the needs of each patient. In rejecting a one-size-fits-all approach, we aim to achieve better patient outcomes and to acknowledge that everyone is different. This is something that may be particularly appreciated by those who have found […]

World Lung Cancer Day: How We Are Advancing Treatments

One date of note for the medical profession in general and oncology in particular is August 1st, when World Lung Cancer Day takes place each year. This occasion helps to raise awareness of the disease, not just in terms of the risk factors for developing it, but also the symptoms that can indicate a problem […]

Amethyst Austria and IASO‑Health Partner to Expand Cancer Care Across Borders

Vienna, Austria / Bad Ragaz, Switzerland – July 16, 2025 Amethyst Radiotherapy Austria , part of the Amethyst Healthcare Group, has entered into a new partnership with IASO‑Health GmbH , a Swiss-based integrative medicine provider led by CEO and Founder Bruno Rosset. This collaboration strengthens cross-border oncology pathways, giving IASO‑Health patients direct access to cutting-edge […]